FI950050A - (S)-timololihemihydraattia sisältävä oftalminen tooppinen koostumus - Google Patents

(S)-timololihemihydraattia sisältävä oftalminen tooppinen koostumus Download PDF

Info

Publication number
FI950050A
FI950050A FI950050A FI950050A FI950050A FI 950050 A FI950050 A FI 950050A FI 950050 A FI950050 A FI 950050A FI 950050 A FI950050 A FI 950050A FI 950050 A FI950050 A FI 950050A
Authority
FI
Finland
Prior art keywords
compsn
adjusters
pref
composition containing
topical composition
Prior art date
Application number
FI950050A
Other languages
English (en)
Swedish (sv)
Other versions
FI112321B (fi
FI950050A0 (fi
Inventor
Markku Peraelampi
Kari Lehmussaari
Olli Oksala
Esko Pohjala
Timo Reunamaeki
Jarkko Ruohonen
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Priority to FI950050A priority Critical patent/FI112321B/fi
Publication of FI950050A publication Critical patent/FI950050A/fi
Publication of FI950050A0 publication Critical patent/FI950050A0/fi
Application granted granted Critical
Publication of FI112321B publication Critical patent/FI112321B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI950050A 1992-07-08 1995-01-04 Menetelmä (S)-timololihemihydraattia sisältävän oftalmisen tooppisen koostumuksen valmistamiseksi FI112321B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI950050A FI112321B (fi) 1992-07-08 1995-01-04 Menetelmä (S)-timololihemihydraattia sisältävän oftalmisen tooppisen koostumuksen valmistamiseksi

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US91066592A 1992-07-08 1992-07-08
US91066592 1992-07-08
PCT/FI1993/000269 WO1994001115A1 (en) 1992-07-08 1993-06-23 Ophthalmic topical composition containing (s)-timolol hemihydrate
FI9300269 1993-06-23
FI950050 1995-01-04
FI950050A FI112321B (fi) 1992-07-08 1995-01-04 Menetelmä (S)-timololihemihydraattia sisältävän oftalmisen tooppisen koostumuksen valmistamiseksi

Publications (3)

Publication Number Publication Date
FI950050A true FI950050A (fi) 1995-01-04
FI950050A0 FI950050A0 (fi) 1995-01-04
FI112321B FI112321B (fi) 2003-11-28

Family

ID=25429138

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950050A FI112321B (fi) 1992-07-08 1995-01-04 Menetelmä (S)-timololihemihydraattia sisältävän oftalmisen tooppisen koostumuksen valmistamiseksi

Country Status (21)

Country Link
EP (1) EP0577913B1 (fi)
JP (1) JP3094233B2 (fi)
KR (1) KR100278851B1 (fi)
AT (1) ATE154513T1 (fi)
AU (1) AU678972B2 (fi)
BR (1) BR9306800A (fi)
CA (1) CA2139781C (fi)
CZ (1) CZ282168B6 (fi)
DE (1) DE69220484T2 (fi)
DK (1) DK0577913T3 (fi)
EE (1) EE03078B1 (fi)
ES (1) ES2106852T3 (fi)
FI (1) FI112321B (fi)
GR (1) GR3024648T3 (fi)
HK (1) HK1007503A1 (fi)
HU (1) HU221618B1 (fi)
NO (1) NO306535B1 (fi)
NZ (1) NZ253164A (fi)
PL (1) PL172503B1 (fi)
SG (1) SG49770A1 (fi)
WO (1) WO1994001115A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69739190D1 (de) * 1996-10-28 2009-02-12 Senju Pharma Co Arzneimittel zur behandlung von oculären kreislauferkrankungen
IT1298758B1 (it) * 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
UA72207C2 (uk) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
WO2004098592A1 (ja) * 2003-05-06 2004-11-18 Senju Pharmaceutical Co. Ltd. オキサゾリジノン誘導体含有組成物
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
JP2014024794A (ja) * 2012-07-27 2014-02-06 Nippon Tenganyaku Kenkyusho:Kk チモロールまたはその薬学的に許容される塩を含有する水性組成物およびその光安定化方法
GR1008483B (el) * 2013-12-23 2015-05-12 Rafarm Α.Ε.Β.Ε., Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195085A (en) 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
GB8822285D0 (en) * 1988-09-22 1988-10-26 Ddsa Pharmaceuticals Ltd Opthalmic preparations
FI82240C (fi) 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.

Also Published As

Publication number Publication date
CA2139781C (en) 2003-09-23
ES2106852T3 (es) 1997-11-16
DK0577913T3 (da) 1998-01-26
KR950702422A (ko) 1995-07-29
AU678972B2 (en) 1997-06-19
EE03078B1 (et) 1998-04-15
DE69220484T2 (de) 1998-02-05
HUT72657A (en) 1996-05-28
SG49770A1 (en) 1998-06-15
NZ253164A (en) 1996-01-26
NO306535B1 (no) 1999-11-22
WO1994001115A1 (en) 1994-01-20
CZ282168B6 (cs) 1997-05-14
AU4329693A (en) 1994-01-31
ATE154513T1 (de) 1997-07-15
EP0577913A1 (en) 1994-01-12
JP3094233B2 (ja) 2000-10-03
EP0577913B1 (en) 1997-06-18
KR100278851B1 (ko) 2001-01-15
JPH07508745A (ja) 1995-09-28
CZ4495A3 (en) 1995-09-13
DE69220484D1 (de) 1997-07-24
NO950059D0 (no) 1995-01-06
HU9500035D0 (en) 1995-03-28
HK1007503A1 (en) 1999-04-16
GR3024648T3 (en) 1997-12-31
PL172503B1 (pl) 1997-10-31
FI112321B (fi) 2003-11-28
BR9306800A (pt) 1998-12-08
HU221618B1 (hu) 2002-12-28
PL307051A1 (en) 1995-05-02
NO950059L (no) 1995-01-06
FI950050A0 (fi) 1995-01-04
CA2139781A1 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
ATE151640T1 (de) Verwendung von protease-inhibitoren als antiexudative, antiphlogistische und antimikrobielle mittel
ES2184836T3 (es) Composiciones que contienen derivados de azol para aplicacion topica en la piel.
MX173433B (es) Composicion acuosa de ibuprofen y procedimiento para su preparacion
ES2098739T3 (es) Composiciones oftalmicas conteniendo una cyclosporin.
DK47189A (da) Bredspektret konserveringsmiddel med synergistisk biocidvirkning
EP0527801A4 (en) Thiophene sulfonamides useful as carbonic anydrase inhibitors
FI88459B (fi) Foerfarande foer framstaellning av en foer intranasal applikation laemplig steroidkomposition
ES2098672T3 (es) Composiciones farmaceuticas estabilizadas que contienen derivados de vitaminas d2 y d3.
ES2178188T3 (es) Composiciones antitusigenas que contienen teobromina.
FI950050A0 (fi) (S)-timololihemihydraattia sisältävä oftalminen tooppinen koostumus
NO901031L (no) Baktericid sammensetning.
ES2113358T3 (es) Composiciones antidiarreicas.
NO934381L (no) Terapeutiske sammensetninger for osteoinduksjon
ATE107853T1 (de) Orales, melatonin enthaltendes arzneimittel.
KR930001903A (ko) 유비데카레논 경구용 수용액 제제
HUT66153A (en) Pharmaceutical compositions which can be used for preventing and treating of chemotherapy-induced alopecia
ATE270114T1 (de) Zusammensetzungen und gegenstände zur verminderung der auswirkung von entzündungen
DK0420798T3 (da) Antimikrobielle præparater
KR880011161A (ko) Ll-f 28249 화합물의 모노-및 디에폭시드 유도체와 그의 사용방법 및 그 유도체를 포함하는 조성물
ATE33759T1 (de) Antimykotische mittel in gelform zur behandlung von pilzinfektionen der mundhoehle.
PT1100463E (pt) Novas formulacoes injectaveis contendo ramoplanina
IT227086Y1 (it) Confezione per sigarette e simili
KR960033467A (ko) 뮤신분비 억제제
CO4180554A1 (es) Composiciones orales que utilizan un componente de peroxido y un componente de bicarbonato, ademas de un portador ade- cuado

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: SANTEN OY

HC Name/ company changed in application

Owner name: RECHERCHE D.C.B.L/D.C.B.L. RESEARCH INC.